ARCHIVES

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

Cancer Centers Branch To Be ‘More Proactive,’ Kimes Tells NCAB

January 12, 1990

ODAC Votes Against Adria’s Chemoprotector, Okays Leustatin

July 3, 1992

Berlin, DeVita Differ On Use Of L-PAM

November 8, 1974

Kentucky Okays Cancer Commission, $1 Million Budget

April 21, 1978

Trials Approved by NCI CTEP For the Month of March

March 30, 2012

FDA’s Jane Henney

February 11, 1994